95
Views
7
CrossRef citations to date
0
Altmetric
Original Research

A toxic organic solvent-free technology for the preparation of PEGylated paclitaxel nanosuspension based on human serum albumin for effective cancer therapy

, , , , , & show all
Pages 7397-7412 | Published online: 11 Dec 2015

References

  • Jose MerlinJPVenkadeshBHussainRPaclitaxel loaded poly-d, l-lactide-co-glycolide nanoparticles: enhanced anticancer effect in non-small cell lung carcinoma cell lineBiomed Prevent Nutr20133119
  • TaoYHanJWangXDouHNano-formulation of paclitaxel by vitamin E succinate functionalized pluronic micelles for enhanced encapsulation, stability and cytotoxicityColloid Surf B Biointerfaces201310260461023104031
  • XinHChenLGuJEnhanced anti-glioblastoma efficacy by PTX-loaded PEGylated poly(ε-caprolactone) nanoparticles: in vitro and in vivo evaluationInt J Pharm20104021–223824720934500
  • SunYYuBWangGEnhanced antitumor efficacy of vitamin E TPGS-emulsified PLGA nanoparticles for delivery of paclitaxelColloid Surf B Biointerfaces201412371672325456995
  • SharmaSVermaATejaBVShuklaPMishraPRDevelopment of stabilized Paclitaxel nanocrystals: In-vitro and in-vivo efficacy studiesEur J Pharm Sci201569516025559064
  • PawarAPVinugalaDBothirajaCNanocochleates derived from nanoliposomes for paclitaxel oral use: preparation, characterization, in vitro anticancer testing, bioavailability and biodistribution study in ratsBiomed Pharmacother2014350219
  • YanFLiLDengZPaclitaxel-liposome-microbubble complexes as ultrasound-triggered therapeutic drug delivery carriersJ Control Release2013166324625523306023
  • LundbergBBRisovicVRamaswamyMWasanKMA lipophilic paclitaxel derivative incorporated in a lipid emulsion for parenteral administrationJ Controll Release200386193100
  • RapoportNGuptaRKimYSO’NeillBEPolymeric micelles and nanoemulsions as tumor-targeted drug carriers: insight through intravital imagingJ Control Release201520615316025776738
  • BouquetWCeelenWFritzingerBPaclitaxel/beta-cyclodextrin complexes for hyperthermic peritoneal perfusion – formulation and stabilityEur J Pharm Biopharm200766339139717240125
  • ChunCLeeSMKimSYYangHKSongSCThermosensitive poly(organophosphazene)-paclitaxel conjugate gels for antitumor applicationsBiomaterials200930122349236019178941
  • GaoLLiuGKangJPaclitaxel nanosuspensions coated with P-gp inhibitory surfactants: I. Acute toxicity and pharmacokinetics studiesColloids Surf B Biointerfaces201311127728123838193
  • SchleichNSibretPDanhierPDual anticancer drug/superparamagnetic iron oxide-loaded PLGA-based nanoparticles for cancer therapy and magnetic resonance imagingInt J Pharm20134471–29410123485340
  • ChinWWParmentierJWidzinskiMTanEHGokhaleRA brief literature and patent review of nanosuspensions to a final drug productJ Pharm Sci2014103102980299925099918
  • LangerKAnhornMGSteinhauserIHuman serum albumin (HSA) nanoparticles: reproducibility of preparation process and kinetics of enzymatic degradationInt J Pharm20083471–210911717681686
  • RanjbarSShokoohiniaYGhobadiSStudies of the interaction between isoimperatorin and human serum albumin by multispectroscopic method: identification of possible binding site of the compound using esterase activity of the proteinScientific World J20132013305081
  • ChatpunSNacharajuPCabralesPImproving cardiac function with new-generation plasma volume expandersAm J Emerg Med2013311546322867830
  • SonSSongSLeeSJSelf-crosslinked human serum albumin nanocarriers for systemic delivery of polymerized siRNA to tumorsBiomaterials201334379475948524050874
  • LiCLiYGaoYDirect comparison of two albumin-based paclitaxel-loaded nanoparticle formulations: is the crosslinked version more advantageous?Int J Pharm20144681–2152524709221
  • IbrahimNIbrahimHDormoiJAlbumin-bound nanoparticles of practically water-insoluble antimalarial lead greatly enhance its efficacyInt J Pharm20144641–221422424412521
  • CrisanteFFrancoliniIBellusciMMartinelliAD’IlarioLPiozziAAntibiotic delivery polyurethanes containing albumin and polyallylamine nanoparticlesEur J Pharm Sci2009364–555556419136061
  • YuSYaoPJiangMZhangGNanogels prepared by self-assembly of oppositely charged globular proteinsBiopolymers200683214815816718679
  • LangerKBalthasarSVogelVDinauerNvon BriesenHSchubertDOptimization of the preparation process for human serum albumin (HSA) nanoparticlesInt J Pharm20032571–216918012711172
  • ElzoghbyAOSamyWMElgindyNAAlbumin-based nanoparticles as potential controlled release drug delivery systemsJ Control Release2012157216818221839127
  • LluchAAlvarezIMunozMSeguiMATusquetsIGarcia-EstevezLTreatment innovations for metastatic breast cancer: nanoparticle albumin-bound (NAB) technology targeted to tumorsCrit Rev Oncol Hematol2014891627224071503
  • GradisharWJAlbumin-bound paclitaxel: a next-generation taxaneExpert Opin Pharmacother2006781041105316722814
  • CatauroMBollinoFPapaleFGallicchioMPacificoSInfluence of the polymer amount on bioactivity and biocompatibility of SiO2/PEG hybrid materials synthesized by sol-gel techniqueMat Sci Eng C Mater Biol Appl201548548555
  • QiuLZhengCJinYZhuKPolymeric micelles as nanocarriers for drug deliveryExpert Opin Ther Patents2007177819830
  • DanhierFLecouturierNVromanBPaclitaxel-loaded PEGylated PLGA-based nanoparticles: in vitro and in vivo evaluationJ Control Release20091331111718950666
  • CuiFLiYZhouSA comparative in vitro evaluation of self-assembled PTX-PLA and PTX-MPEG-PLA nanoparticlesNanoscale Res Lett20138130130823806106
  • HahnenkampAAlsibaiWBremerCHoltkeCOptimizing the bio-availability of small molecular optical imaging probes by conjugation to an albumin affinity tagJ Control Release2014186324024815420
  • ZhongYYangWSunHLigand-directed reduction-sensitive shell-sheddable biodegradable micelles actively deliver doxorubicin into the nuclei of target cancer cellsBiomacromolecules201314103723373023998942
  • XieJChenKHuangJPET/NIRF/MRI triple functional iron oxide nanoparticlesBiomaterials201031113016302220092887
  • WangHSunXGaoFZhongBZhangYHSunZEffect of ulinastatin on growth inhibition, apoptosis of breast carcinoma cells is related to a decrease in signal conduction of JNk-2 and NF-kappaBJ Exp Clin Cancer Res20123111322208663
  • PelzerESHarrisJEAllanJATUNEL analysis of DNA fragmentation in mouse unfertilized oocytes: the effect of microorganisms within human follicular fluid collected during IVF cyclesJ Reprod Immunol2013991–2697923972717
  • WuDZhengYHuXFanZJingXAnti-tumor activity of folate targeted biodegradable polymer-paclitaxel conjugate micelles on EMT-6 breast cancer modelMater Sci Eng C Mater Biol Appl201553687526042692
  • DangYZhuCGenomic study of the absorption mechanism of cantharidin and its solid dispersionColloid Surf A Physicochem Eng Asp2012415295301
  • LiuXLuMGuoZHuangLFengXWuCImproving the chemical stability of amorphous solid dispersion with cocrystal technique by hot melt extrusionPharm Res201229380681722009589
  • LimaAASoares-SobrinhoJLSilvaJLThe use of solid dispersion systems in hydrophilic carriers to increase benzonidazole solubilityJ Pharm Sci201110062443245121491453
  • BekaleLAgudeloDTajmir-RiahiHAThe role of polymer size and hydrophobic end-group in PEG-protein interactionColloid Surf B Biointerfaces201513014114825865167
  • YadavSKMishraSMishraBEudragit-based nanosuspension of poorly water-soluble drug: formulation and in vitro-in vivo evaluationAAPS Pharm Sci Tech201213410311044
  • GuoSHuangLNanoparticles escaping RES and endosome: challenges for siRNA delivery for cancer therapyJ Nanomater2011201111
  • MaedaHBharateGYDaruwallaJPolymeric drugs for efficient tumor-targeted drug delivery based on EPR-effectEur J Pharm Biopharm200971340941919070661
  • WuLZhangJWatanabeWPhysical and chemical stability of drug nanoparticlesAdv Drug Deliv Rev201163645646921315781
  • HuoMZhangYZhouJSynthesis and characterization of low-toxic amphiphilic chitosan derivatives and their application as micelle carrier for antitumor drugInt J Pharm20103941–216217320457237
  • FreiEAlbumin binding ligands and albumin conjugate uptake by cancer cellsDiabetol Metab Syndr2011311121676260
  • GaoLLiuGMaJPaclitaxel nanosuspension coated with P-gp inhibitory surfactants: II. Ability to reverse the drug-resistance of H460 human lung cancer cellsColloid Surf B Biointerfaces201411712212724632038
  • FangJLiaoLYinHNakamuraHShinTMaedaHEnhanced bacterial tumor delivery by modulating the EPR effect and therapeutic potential of Lactobacillus caseiJ Pharm Sci2014103103235324325041982
  • LuJHuangYZhaoWDesign and characterization of PEG-derivatized vitamin E as a nanomicellar formulation for delivery of paclitaxelMol Pharm20131082880289023768151
  • GligorovJLotzJPPreclinical pharmacology of the taxanes: implications of the differencesOncologist20049Suppl 23815161985
  • GongJHuoMZhouJSynthesis, characterization, drug-loading capacity and safety of novel octyl modified serum albumin micellesInt J Pharm20093761–216116819409461
  • ten TijeAJVerweijJLoosWJSparreboom A. Pharmacological effects of formulation vehicles: implications for cancer chemotherapyClin Pharmacokinet200342766568512844327